ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Leap Therapeutics Inc

Leap Therapeutics Inc (LPTX)

0.483
0.002
(0.42%)
마감 26 2월 6:00AM
0.483
0.00
(0.00%)
시간외 거래: 9:37AM

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
1.000.050.050.050.050.000.00 %0186-
2.000.050.050.050.050.000.00 %028-
3.000.050.050.050.050.000.00 %0359-
4.000.050.750.050.400.000.00 %01,285-
5.000.680.750.680.7150.000.00 %017-
6.000.400.750.400.5750.000.00 %052-
7.000.102.350.101.2250.000.00 %057-

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
1.000.450.850.550.650.000.00 %0800-
2.001.301.551.521.4250.000.00 %037-
3.000.103.702.511.900.000.00 %015-
4.001.005.001.143.000.000.00 %07-
5.002.406.604.454.500.000.00 %00-
6.004.605.700.005.150.000.00 %00-
7.004.108.500.006.300.000.00 %00-

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ONVOOrganovo Holdings Inc
US$ 1.2502
(238.81%)
386.27M
RETOReTo Eco Solutions Inc
US$ 1.065
(80.51%)
78.71M
VEROVenus Concept Inc
US$ 0.5402
(76.54%)
15.55M
SLXNSilexion Therapeutics Corporation
US$ 1.23
(64.00%)
87.74M
WAFUWah Fu Education Group Ltd
US$ 2.825
(57.82%)
125.46M
YYAIConnexa Sports Technologies Inc
US$ 0.681
(-46.38%)
6.22M
RNAZTransCode Therapeutics Inc
US$ 4.34
(-35.99%)
611.44k
ACONAclarion Inc
US$ 3.25
(-30.26%)
417.53k
BTDRBitdeer Technologies Group
US$ 9.255
(-29.35%)
16.96M
NKLANikola Corporation
US$ 0.184
(-28.35%)
37.07M
ONVOOrganovo Holdings Inc
US$ 1.2502
(238.81%)
386.27M
NVDANVIDIA Corporation
US$ 126.63
(-2.80%)
271.57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 14.41
(-16.85%)
167.52M
SMCISuper Micro Computer Inc
US$ 45.54
(-11.76%)
146.56M
TSLATesla Inc
US$ 302.80
(-8.39%)
134.25M

LPTX Discussion

게시물 보기
Monksdream Monksdream 3 주 전
LPTX, new 52/low
👍️0
glenn1919 glenn1919 4 주 전
LPTX.......................................................bottomplay.......................................https://stockcharts.com/h-sc/ui?s=lptx&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 4 주 전
.50s seems good for an entry after the brutal dump in some .54 
👍️0
Deano361 Deano361 1 월 전
Bad day today but when this gets the data results and they go to market on the drug, this is an easy 10x stock.
👍️0
ANTADOG ANTADOG 1 월 전
nice volume comin' in, 3,22~~, ANT
👍️0
ANTADOG ANTADOG 2 월 전
added some more, only partial fill, ANT
👍️0
ANTADOG ANTADOG 2 월 전
nice chart setup, solid 3,50 break gettin' closer, ANT
👍️0
ANTADOG ANTADOG 2 월 전
4's towards nxt update and jp conference almost a given, ANT
👍️0
ANTADOG ANTADOG 2 월 전
touchin' 3's again, so little vol needed, nxt update should be saweet imvho ANT
👍️0
ANTADOG ANTADOG 2 월 전
touched 3 again, small prelude of things to come, imosho ANT
👍️0
ANTADOG ANTADOG 2 월 전
hearin' some good things comin' our way, hmm, u got to pay to play, ANT
👍️0
ANTADOG ANTADOG 2 월 전
Added 2,96~~ ANT
👍️0
ANTADOG ANTADOG 3 월 전
3,40~~ because they know... ANT
👍️0
ANTADOG ANTADOG 3 월 전
accumulated a nice amount around 3 bucks, longterm, ANT
👍️0
ANTADOG ANTADOG 3 월 전
3,35~~ ANT
👍️0
ANTADOG ANTADOG 3 월 전
3,33~~ ANT
👍️0
ANTADOG ANTADOG 3 월 전
Volume intact, ANT
👍️0
ANTADOG ANTADOG 3 월 전
hooverin' above 3 bucks, ceo certainly gave them somethin' to think about, to be continued.... ANT
👍️0
ANTADOG ANTADOG 3 월 전
3,33~~ ANT
👍️0
ANTADOG ANTADOG 3 월 전
3,24~~ ANT
👍️0
ANTADOG ANTADOG 3 월 전
3,19~~ ANT
👍️0
ANTADOG ANTADOG 3 월 전
mm in trouble lol, ANT
👍️0
ANTADOG ANTADOG 3 월 전
3,12~~ ANT
👍️0
ANTADOG ANTADOG 3 월 전
3,10 break is close, hmm, ANT
👍️0
ANTADOG ANTADOG 3 월 전
added some 2,80's, likin' the chart, ANT
👍️0
glenn1919 glenn1919 3 월 전
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
ANTADOG ANTADOG 4 월 전
And some more 3,25's longterm, ANT
👍️0
ANTADOG ANTADOG 4 월 전
added 3,70 ANT
👍️0
ANTADOG ANTADOG 4 월 전
held first support, startin' to like this one more and more, gild support, fyi ANT
👍️0
ANTADOG ANTADOG 4 월 전
added first support, ANT
👍️0
ANTADOG ANTADOG 4 월 전
consistent buyin' often means deeper pockets like what they see or are about to find out, so they add while it's cheap, imo but we'll see soon, ANT
👍️0
ANTADOG ANTADOG 4 월 전
puppy's goin' for a new 52wk high imo ANT
👍️0
ANTADOG ANTADOG 4 월 전
because it's a double digitland stock, xcellent results will propel it imosho ANT
👍️0
joelawyer joelawyer 4 월 전
Any clue what's driving this major upside move the last week?

👍️0
glenn1919 glenn1919 4 월 전
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 4 월 전
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 6 월 전
LPTX under $3
👍️0
Monksdream Monksdream 7 월 전
LPTX under $3
👍️0
Monksdream Monksdream 8 월 전
LPTX under $2
👍️0
Monksdream Monksdream 10 월 전
LPTX under $5
👍️0
glenn1919 glenn1919 10 월 전
LPTX...................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 12 월 전
LPTX 10Q due March 12
👍️0
glenn1919 glenn1919 1 년 전
LPTX.......................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 년 전
LPTX................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 년 전
LPTX new 52 week low
👍️0
Monksdream Monksdream 1 년 전
LPTX new 52 week low
👍️0
Slicky1315 Slicky1315 2 년 전
Wow..almost a year and no one posted anything!!
👍️0
VivaLasVegas VivaLasVegas 3 년 전
No one in their right mind gives 2 Sheets what some joke analyst gives for any price target

They are Shills
👍️0
stockguard stockguard 3 년 전
LPTX Piper ups Leap Therapeutics target to $6 following DKN-01's ASCO GI Update Jan. 23
Piper Sandler analyst Joseph Catanzaro raised the firm's price target on Leap Therapeutics (LPTX) to $6 from $5 and keeps an Overweight rating on the shares. Following the ASCO GI update for DKN-01, Leap hosted a conference call on Friday to walk through the data and lay out potential next steps, the analyst notes. When considering potential treatment effect, Catanzaro thinks the signal in DKK1-high patients looks even more compelling. Leap believes it could initiate a small randomized Phase II as part of the current IND that could generate data in 2023, while simultaneously engaging regulatory agencies on registrational strategies. Most notably, BeiGene's (BGNE) opt-in decision for Asian rights will almost certainly be a 2022 event, and the analyst continues to believe the ASCO GI update should make that a straightforward choice.
👍️0
Deano361 Deano361 3 년 전
yep, something big happening here.
👍️0